But embryonic stem cell research is a multi-billion dollar industry with support and backing from the media, Wall Street and now the U.S. government, according to Carter. And organizations such as STEMTech, which are working to advance the scientific progress of adult stem cells, are being looked over.
Christian Drapeau, author of "The Stem Cell Theory of Renewal," also feels that Obama's decision could drive critical resources away from adult stem cells, and he thinks they actually have the greater potential for human wellness.
STEMTech HealthSciences owns the rights to StemEnhance, a patented product proven to enhance adult stem cell release in a person's body. The company has expanded into eight countries since 2006 with its Stem Cell Nutrition product line.